- $17.10bn
- $14.71bn
- $4.24bn
- 95
- 52
- 90
- 94
Annual balance sheet for Incyte, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,801 | 2,348 | 3,239 | 3,656 | 2,158 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 482 | 616 | 645 | 744 | 853 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 2,360 | 3,119 | 4,093 | 4,645 | 3,239 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 588 | 751 | 766 | 777 | 794 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 3,561 | 4,933 | 5,841 | 6,782 | 5,444 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 631 | 854 | 1,157 | 1,240 | 1,642 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 950 | 1,163 | 1,471 | 1,592 | 1,997 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 2,611 | 3,770 | 4,370 | 5,190 | 3,448 |
| Total Liabilities & Shareholders' Equity | 3,561 | 4,933 | 5,841 | 6,782 | 5,444 |
| Total Common Shares Outstanding |